This compound is a protected peptide building block containing a histidine derivative with a trityl protecting group and an alpha-methylalanine (Aib) residue, modified with a fluorenylmethoxycarbonyl (Fmoc) group. It is used in research for the solid-phase synthesis of peptides that require sterically hindered amino acids.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N-Fmoc-N'-trityl-L-histidine
pharmaceutical intermediate
N-Fmoc-N'-trityl-D-histidine
pharmaceutical intermediate
Fmoc-His(Trt)-Gly-OH
research compound
Fmoc-N'-Acetyl-L-lysine
research compound
Fmoc-N-methyl-L-alloisoleucine
research compound
(S)-N-Fmoc-4-Bromophenylalanine
research compound
4-Methylphenyl-L-alanine
research compound
Palmitic acid N-hydroxysuccinimide ester
research compound
2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(1-tritylimidazol-4-yl)propanoyl]amino]-2-methylpropanoic acid
DGCYUQQCKAJBGR-KDXMTYKHSA-N
CC(C)(C(=O)O)NC(=O)[C@H](CC1=CN(C=N1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4)NC(=O)OCC5C6=CC=CC=C6C7=CC=CC=C57
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.